Alexandre Allegret, Co-Founder of MyBiotech, is a multifaceted professional whose expertise spans corporate restructuring, biotechnology, and public service. With an impressive academic background that includes an MBA, MPA, and qualifications in economics, law, and biology, Alexandre brings a unique blend of analytical and strategic skills...
Alexandre Allegret, Co-Founder of MyBiotech, is a multifaceted professional whose expertise spans corporate restructuring, biotechnology, and public service. With an impressive academic background that includes an MBA, MPA, and qualifications in economics, law, and biology, Alexandre brings a unique blend of analytical and strategic skills to the forefront of the biotech industry. At MyBiotech, he plays a pivotal role in developing innovative disinfection solutions tailored for highly demanding operations, addressing the critical need for effective sanitation in healthcare, pharmaceuticals, and other sectors where hygiene is paramount.
Under Alexandre's leadership, MyBiotech has embarked on key projects that leverage advanced technologies and rigorous scientific methodologies to enhance disinfection processes. His proficiency in business analysis and valuation, combined with programming skills in languages such as Python, C++, and Visual Basic, enables him to lead cross-functional teams in creating data-driven solutions that meet the stringent requirements of the industry. Alexandre's strategic vision is complemented by his experience in consulting, allowing him to navigate complex regulatory landscapes and foster partnerships that drive growth and innovation.
In addition to his corporate endeavors, Alexandre serves as a town councillor in Fillière, Haute-Savoie, where he applies his analytical skills to local governance and community development. This dual role enriches his perspective on the intersection of biotechnology and public health, positioning him as a thought leader in the field. With a commitment to advancing biotechnological applications and a passion for improving public health outcomes, Alexandre Allegret is at the forefront of shaping the future of disinfection solutions in the biotech landscape.
